ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION OF PANCREATIC METASTASIS FROM RENAL CELL CANCER: FEASIBILITY AND SAFETY

Aims Renal cell carcinoma (RCC) is the most common renal cancer in adults. Up to 50% of patients will develop metastases after nephrectomy with a 5-year survival rate of 10%-15%. Pancreas is an elective site for RCC metastases. Surgery is the first choice treatment for pancreatic metastases. For not-resectable pancreatic metastases therapeutical options are limited. Radiofrequency ablation (RFA) has been successfully performed for the treatment...